Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
To investigate the effects of simvastatin in patients with heterozygous familial hypercholesterolaemia refractory or intolerant to routine drug therapy. Eighteen patients were given increasing doses of 10, 20 and 40 mg simvastatin for eight week periods, followed by a control period on their former drug therapy in a prospective, crossover clinical study. Mean total and low density lipoprotein cholesterol (SEM) were significantly lower on 40 mg simvastatin alone than at the end of the control period (7.3 (0.3) mmol/L vs 10.7 (0.4) and 5.1 (0.3) vs 7.8 (0.5) respectively; p less than 0.01). Apo-B was also significantly lower on 40 mg simvastatin (p less than 0.01). Simvastatin offers effective cholesterol lowering for patients with drug resistant familial hypercholesterolaemia.